CFTR and cystic fibrosis: The pluripotency and genomic profile of the iPSC cell lines have been validated as a resource that can be used for pharmacological investigations and drug screening associated with mutations of CFTR genes and provide hope for curing cystic fibrosis in the future (Merkert et al., 2020).